10 September 2026
QV Bioelectronics Selected to Present at LSI Europe ’26
QV Bioelectronics has been selected to present at LSI Europe '26, one of medtech's leading showcase events, in Barcelona this September. CEO Carl Daintree will […]
5 August 2026
Why the UK Needs a National Brain Cancer Strategy
Yesterday, Archie Goodburn appeared on BBC Breakfast calling for a national brain cancer lead and better access to international clinical trials for UK patients. His […]
31 July 2026
QV Bioelectronics Featured in NIHR 2025/26 Annual Report
QV Bioelectronics has been spotlighted in the National Institute for Health and Care Research (NIHR) 2025/26 Annual Report, recognised in the Investment chapter for the […]
26 June 2026
Welcoming Robert to the QV Bioelectronics Team
We’re excited to welcome Robert to QV Bioelectronics as our new Electronic Systems Engineer! Robert brings deep expertise in mixed-signal electronics, high-density PCB design and […]
15 June 2026
QV Bioelectronics Marks World Brain Tumour Day with Major Milestone for SHIELD Study
Last week on World Brain Tumour Day, QV Bioelectronics reached an important milestone in the development of GRACE, the world's first fully implantable Tumour Treating […]
9 April 2026
Eduard Fedorov joins QV Bioelectronics as Senior Physicist
We’re excited to welcome Eduard Fedorov to QV Bioelectronics!Eduard is a seasoned physicist and technology leader, with over 15 years of interdisciplinary experience spanning advanced […]
Interested in Receiving our Press Releases?